Evaluation of drug vulnerability of NF2 tumor models

NF2 tumors are very rare and understudied tumor around rare pediatric brain tumor research field. There are only very few cell lines in the field derived from specimens from subjects carrying NF2 mutation and they are of limited availability. Using models from CBTN and NF2 Biosolutions is essential
for the project.